|

Icotinib Clinical Trials

3 actively recruiting trials

▲ +1 trial since August 2026

Also known as: Conmana

Pipeline

Phase 2: 2

Top Sponsors

  • Sun Yat-sen University1
  • Peking University Cancer Hospital & Institute1
  • Betta Pharmaceuticals Co., Ltd.1

Indications

Other3 trials

A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
Phase 2
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Phase 2
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.